FROM THE EUROPEAN UNION
EUROPEAN COMMISSION LAUNCHES A PUBLIC CONSULTATION ON THE PAEDIATRIC REGULATION
The European Commission (EC) has launched a public consultation to get views and feedback from stakeholders, to support the Commission in drafting its second report on the Paediatric Regulation after nearly ten years of implementation. The consultation is open until 20 February 2017. Stakeholders should send their comments directly to the EC by accessing the consultation page.
The feedback received will form an integral part of the Commission’s final report assessing the impact of the Paediatric Regulation on public health and the pharmaceutical industry, which is expected to be published in 2017.
The Paediatric Regulation came into force in the European Union (EU) on 26 January 2007. Its objective is to improve the health of children in Europe by facilitating the development and availability of age-appropriate medicines for children, and by increasing available information on the use of medicines for children.
For more information please click here.
ESDPPP VZW p/a University Hospital
Gasthuisberg Herestraat 49
The primary aim of the society is to promote research in the field of paediatric pharmacology and to offer a forum for exchange between pharmacologists and clinical physicians about more adequate drug administration.
Join us on LinkedIn